The prototypical mutation leading to EGFR‐TKI resistance in NSCLC is the EGFR‐T790M mutation, found in ≥50% of patients with acquired resistance to early‐generation EGFR TKIs.24, 25. This evidence concerns the gene EGFR and non-small cell lung carcinoma.